Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-008895-15Phase 4Active
Phase 4, open-label, single-arm trial of sirolimus in Kidney allograft status (RTx), sponsored by Hospices Civils de Lyon. Primary endpoint: Sirolimus-related adverse effects. Started Mar 2009; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-008895-15.